Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€0.82

€0.82

3.130%
0.025
3.130%
€2.00
 
22.04.24 / Tradegate WKN: A3H210 / Name: Aap Implantate / Stock / ? /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

Aap Implantate AG Stock

Aap Implantate AG dominated the market today, gaining €0.025 (3.130%).
With 0 Sell predictions and 1 Buy predictions the community sentiment towards the Aap Implantate AG stock is not clear.
Based on the current price of 0.82 € the target price of 2 € shows a potential of 145.4% for Aap Implantate AG which would more than double the current price.
For the coming years our community has positive and negative things to say abot the Aap Implantate AG stock. Criterium "Business model" gathered the most positive votes but regarding "Valuation (undervalued/overvalued)" there were negative voices in the community.

Pros and Cons of Aap Implantate AG in the next few years

Pros
?
B****
?
G***** c******* t* c**********
?
S********** s********
Cons
?
M***** P*******
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'

sharewise BeanCounterBot

The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
Last updated at 2023-05-27

At first glance, the financials of Aap Implantate, a company operating within the industry, appears to be a mixed bag. There are certain positive aspects, as well as some areas of concern that potential investors should be aware of. Below is a detailed analysis of the pros and cons associated with the company's financials in order to provide a comprehensive understanding of the business and its potential for growth.

*Pros: *

Revenue and Gross Profit Growth: Aap Implantate has demonstrated consistent growth in its total revenue on a yearly basis from 2020–2022. In addition, the company has been able to maintain a healthy gross profit over these years, with a slight increase between 2020 and 2021.

Comments

systinvest hat das Wertpapier Aap Implantate AG in seinem Wikifolio Aktienwertselektion mit System gekauft.
Show more

News

EQS-News: aap closes Q1 2024 with sales growth of 5.6% and positive developments at all operating levels and makes a strong start to Q2 2024
EQS-News: aap closes Q1 2024 with sales growth of 5.6% and positive developments at all operating levels and makes a strong start to Q2 2024
EQS-News: aap closes Q1 2024 with sales growth of 5.6% and positive developments at all operating levels and makes a strong start to Q2 2024
EQS-News: aap successfully places a 10% capital increase from authorized capital at EUR 1.10 with exclusion of subscription rights
EQS-News: aap successfully places a 10% capital increase from authorized capital at EUR 1.10 with exclusion of subscription rights
EQS-News: aap successfully places a 10% capital increase from authorized capital at EUR 1.10 with exclusion of subscription rights
EQS-Adhoc: aap Implantate AG: aap postpones publication of the consolidated financial statements 2023 due to staff shortages
EQS-Adhoc: aap Implantate AG: aap postpones publication of the consolidated financial statements 2023 due to staff shortages
EQS-Adhoc: aap Implantate AG: aap postpones publication of the consolidated financial statements 2023 due to staff shortages